Skip to main content
Signal8

Ocugen, Inc. (OCGN)

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis. OCU410: Another gene therapy candidate, currently being developed to address dry age-related macular degeneration (AMD). OCU200: A novel fusion protein, presently undergoing preclinical evaluation for its potential in treating diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen maintains significant strategic collaborations, including a partnership with CanSino Biologics Inc. for the joint development and manufacturing of gene therapies, and an alliance with Bharat Biotech for the commercialization of COVAXIN within the United States market. The company's corporate headquarters are situated in Malvern, Pennsylvania.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Ocugen, Inc. logo

Ocugen, Inc.

NASDAQ:OCGNHealthcare
-5.58%$0.7027
AH$0.7192+2.35%vs close
Mkt Cap$238.29M
Float331.4M
O/S339.11M
Vol
$ Vol
RVOL
Inst Own43.0%
SI32.3%
Earnings
Dilution
Financials Summary
Revenue$4.41M
Net Income-$67.85M
Total Assets$43.52M
Free Cash Flow-$57.15M
Debt & Equity
Debt 158%
Total Debt$33.14M
Total Equity-$12.17M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in OCGN's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$43.52M
Liabilities$55.68M
Accounts Receivable$0
Accounts Payable$6.2M
Inventory$0
PP&E (Net)$14.39M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$4.41M$4.05M$6.04M$2.49M$0$43K$0$0$0$0$0$0$8K$26K
YoY Growth8.8%-32.8%142.6%----------69.2%-
Cost of Revenue$2.39M$1.97M$704K$0$0$6.35M$8.09M$50K$1.53M$1.67M$1.61M$0$0$0
Gross Profit$2.02M$2.09M$5.33M$2.49M$0-$6.31M-$8.09M-$50K-$1.53M-$1.67M-$1.61M$0$8K$26K
Gross Margin45.9%51.5%88.3%100.0%--14676.7%------100.0%100.0%
Research and Development$39.75M$32.13M$39.57M$56.16M$35.11M$13.35M$8.09M$15.63M$15.57M$21.58M$23.24M$25.86M$11.95M$11.94M
Selling, General, and Administrative$27.58M$26.69M$31.99M$35.4M$22.92M$7.97M$6.08M$10.2M$9.38M$8.53M$8.27M$6.75M$4.85M$3.05M
Other-$2.39M-$1.97M-$704K$0$0-$6.35M-$8.09M$0-$116K-$248K-$72K$13K-$52K-$30K
Total Operating Expenses$64.94M$56.84M$70.86M$91.56M$58.03M$14.97M$6.08M$25.84M$24.95M$30.11M$31.51M$32.6M$16.79M$14.99M
Operating Income (EBIT)-$62.92M-$54.76M-$65.53M-$89.07M-$58.03M-$21.29M-$14.16M-$30.11M-$24.95M-$30.31M-$31.82M-$32.66M-$16.84M-$14.97M
Operating Margin-1425.7%-1350.4%-1085.7%-3580.0%--49500.0%-------210562.5%-57569.2%
Interest Expense$5.19M$0$0$0$79K$721K$1.77M$163K$134K-$60K-$133K-$151K$0$798K
Interest Income$922K$1.3M$2.5M$1.4M$0$1K$1K$0$0$0$0$0$0$0
Other Income (Expense)-$4.93M$703K$2.45M$2.27M-$389K-$537K-$6.08M$11.89M-$1.46M$14.1M-$205K$9.87M-$8.87M-$1.97M
Income Before Tax (EBT)-$67.85M-$54.05M-$63.08M-$86.8M-$58.42M-$21.82M-$20.24M-$8.64M-$26.41M-$16.21M-$32.02M-$22.79M-$25.71M-$16.93M
Income Tax Expense$0$0$0$0-$52K$0$0-$15.76M-$186K$0$0$0$0$0
Net Income-$67.85M-$54.05M-$63.08M-$86.8M-$58.37M-$21.82M-$20.24M-$8.64M-$26.41M-$16.21M-$32.02M-$22.79M-$25.71M-$16.93M
Net Income Margin-1537.4%-1333.0%-1045.0%-3488.9%--50748.8%-------321400.0%-65134.6%
Supplementary Data
EPS-0.23-0.20-0.26-0.40-0.30-0.31-1.53-13.98-69.91-68.21-145.22-891.47-120.93-79.65
Diluted EPS-0.23-0.20-0.26-0.40-0.30-0.31-1.53-13.98-69.91-67.58-145.22-891.47-120.93-79.65
Weighted Average OS300.17M271.00M244.33M214.60M195.01M112.24M13.89M618,182377,830237,620220,51825,568212,617212,617
EBITDA-$60.27M-$52.09M-$62.37M-$86.32M-$58.11M-$14.18M-$14.1M-$14.42M-$24.88M-$11.38M-$30.28M-$21.92M-$16.22M-$14.33M
EBITDA Margin-1365.7%-1284.5%-1033.4%-3469.6%--32983.7%-------202737.5%-55115.4%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$18.57M$58.51M$39.46M$77.56M$94.96M$24.04M$7.44M$15.54M$7.08M$31.91M$30.91M$58.06M$8.73M$14.72M
Short-Term Investments$0$0$0$13.37M$0$0$0$0$900K$0$0$0$0$0
Cash and Short-Term Investments$18.57M$58.51M$39.46M$90.93M$94.96M$24.04M$7.44M$15.54M$7.98M$31.91M$30.91M$58.06M$8.73M$14.72M
Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$5.77M$3.17M$3.51M$7.56M$0$0$7M$172K$122K$78K$279K$729K$1.13M$340K
Total Current Assets$24.34M$61.68M$42.97M$98.49M$102.65M$25.88M$15.77M$16.4M$8.18M$32.08M$31.24M$58.86M$10.35M$15.08M
Long-Term Assets
Property, Plant & Equipment Net$14.39M$16.55M$17.29M$6.05M$1.16M$633K$222K$141K$2.72M$3.86M$5.21M$4.88M$2.28M$2.31M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$200K$510K$570K$630K
Long-Term Investments$0$0$0$0$0$0$151K$150K$137K$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$651K$1.06M$2.48M
Other Long-Term Assets$4.78M$4.21M$4.29M$4.09M$1.95M$865K$668K$737K$0$137K$137K$604K$539K$540K
Total Long-Term Assets$19.18M$20.76M$21.58M$10.14M$3.12M$1.5M$1.04M$1.03M$2.86M$4M$5.55M$6.64M$4.45M$5.96M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$43.52M$82.44M$64.55M$108.63M$105.76M$27.38M$16.81M$17.43M$11.04M$36.08M$36.79M$65.5M$14.8M$21.04M
Liabilities
Current Liabilities
Accounts Payable$6.2M$4.24M$3.17M$8.06M$2.31M$395K$1.9M$1.59M$776K$1.95M$2.25M$4.89M$2.53M$1.04M
Short-Term Debt$1.25M$1.33M$0$0$0$234K$0$0$178K$583K$583K$405K$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$5.91M$8.37M$10.53M$11.22M$0$0$2.27M$10M$2.02M$2.13M$2.98M$2.83M$0$0
Other Current Liabilities$6.69M$5.25M$1.03M$3.11M$1.72M$1.68M-$2.06M$948K$1.18M$1.24M$2.77M$2.22M$1.69M$1.14M
Total Current Liabilities$23.04M$21.59M$17.09M$28.53M$7M$3.61M$4.54M$2.87M$3.81M$5.17M$6.36M$8.25M$5.09M$4.4M
Long-Term Liabilities
Long-Term Debt$27.54M$27.34M$2.8M$2.29M$1.71M$1.82M$1.07M$1.02M$0$178K$761K$1.34M$0$0
Long-Term Unearned Revenue$0$0-$918K$0$0$0$0$10M$0$0$0-$2M$0$0
Long-Term Deferred Tax Liabilities$0$0$918K$0$0$0$0-$1.02M$0$0$0$651K$0$0
Other Long-Term Liabilities$1.6M$564K$527K$244K$0$0$10K$4M$18.5M$17.16M$1.47M$1.05M$85.26M$36.35M
Total Long-Term Liabilities$32.64M$31.22M$6.89M$6.12M$2.94M$2.21M$1.25M$15.01M$18.5M$17.34M$2.23M$3.04M$85.26M$36.35M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$55.68M$52.81M$23.98M$34.65M$9.94M$5.83M$5.79M$17.89M$22.3M$22.51M$8.59M$11.29M$90.35M$40.76M
Stockholders' Equity
Preferred Stock$0$0$1K$1K$1K$0$0$0$0$0$0$0$0$0
Common Stock$3.13M$2.92M$2.57M$2.22M$2M$1.84M$527K$513K$159K$159K$132K$127K$6K$6K
Retained Earnings-$408.07M-$340.22M-$286.17M-$223.09M-$131.67M-$73.3M-$51.48M-$216.83M-$208.19M-$181.77M-$165.56M-$133.54M-$110.75M-$85.04M
Comprehensive Income & Other$61K$48K$20K$26K-$0$0$0-$10.29M-$10.92M-$9.39M-$7.99M-$6.38M-$5.65M-$5.15M
Other Stockholders' Equity$392.78M$366.94M$324.16M$294.85M$225.49M$93.01M$61.97M$215.86M$196.76M$195.18M$193.63M$187.62M$35.19M$65.32M
Total Equity-$12.17M$29.63M$40.56M$73.98M$95.82M$21.55M$11.02M-$458K-$11.27M$13.57M$28.2M$54.21M-$75.55M-$19.71M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$43.52M$82.44M$64.55M$108.63M$105.76M$27.38M$16.81M$17.43M$11.04M$36.08M$36.79M$65.5M$14.8M$21.04M
Supplementary Data
Total Debt$33.14M$32.5M$6.94M$6.37M$3.31M$2.49M$1.41M$238K$178K$761K$1.34M$1.75M$0$0
Net Debt$14.57M-$26.01M-$32.52M-$71.19M-$91.65M-$21.55M-$6.04M-$15.3M-$6.9M-$31.15M-$29.57M-$56.31M-$8.73M-$14.72M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$67.85M-$54.05M-$63.08M-$86.8M-$58.37M-$21.82M-$20.24M-$8.64M-$26.41M-$16.21M-$32.02M-$22.79M-$25.71M-$16.93M
Depreciation & Amortization$2.39M$1.97M$704K$480K$229K$102K$61K$50K$1.53M$1.67M$1.61M$726K$566K$638K
Deferred Income Tax$0$0$0$0-$52K$0$3.19M-$17.14M$1.54M-$14.21M$321K$60K$80K$2.43M
Stock-Based Compensation$7.71M$7.43M$9.22M$10.54M$6.96M$660K$884K$1.63M$1.57M$1.55M$1.23M$547K$158K$14K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$3.5M-$540.85M-$1.63B-$375K-$1.21M-$304K-$2.63M$2.03M$804K-$228K
  Other Working Capital-$523K$3.67M-$13.16M$9.2M-$1.01M$539.64M$1.63B-$2.43M$503K$2.29M$1.78M$357K$462K$276K
Total Working Capital Change-$523K$3.67M-$13.16M$9.2M$2.49M-$1.21M-$3.11M-$2.81M-$706K$1.99M-$851K$2.38M$1.27M$48K
Other Non-Cash Items$1.31M-$1.15M$4.26M$6.51M$799K$7.56M$2.33M$11.13M-$543K-$533K-$322K$672K$8.36M$1.57M
Net Cash from Operating-$56.96M-$42.14M-$62.05M-$60.08M-$47.94M-$14.71M-$16.89M-$15.78M-$23.02M-$25.74M-$30.03M-$18.41M-$15.28M-$12.23M
Investing Activities
Capital Expenditures-$185K-$3.38M-$10.48M-$4.46M-$939K-$307K-$29K-$2.01M-$276K-$320K-$1.95M-$3.32M-$604K-$79K
Acquisitions$0$0$0$0$0$0-$2.33M$0$0$0$0$0$0$0
Purchases of Investments$0$0-$3.95M-$13.27M$0$0$0$0-$8M$0$0$0$0$0
Sales of Investments$0$0$17.5M$0$0$0$0$900K$7.05M$0$0$0$0$0
Other Investing Activities-$126K$0$0$761K-$877K$0-$273$0$0$0$0$0$50K$0
Net Cash from Investing-$311K-$3.38M$3.08M-$16.97M-$1.82M-$307K-$2.36M-$1.11M-$1.23M-$320K-$1.95M-$3.32M-$554K-$79K
Financing Activities
Debt Repaid$1M-$30M-$500K-$500K$10K$4.73M-$1.48M$178K$583K$583K$406K-$1.75M--$6.01M
Common Stock Issuance$18.33M$38.56M$20.8M$59.57M$129.21M$37.82M$1.18M$25.53M$6K$27.63M$4.74M$60.45M$0$0
Common Stock Repurchases$0$0$0$0$0$0-$48K$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0-$3.7M-$68K-$592K-$8.53M-$1.48M$0$3K$6K$2K$39K-$1.46M-$407K$0
Net Cash from Financing$17.33M$64.86M$20.88M$59.48M$120.68M$31.61M$25.07M$25.35M-$577K$27.05M$4.37M$71.05M$9.85M$26.69M
Forex Effect$13K$28K-$5K$25K-$325$0$0$451$0$0$0$0$0$0
Net Change in Cash-$39.93M$19.36M-$38.1M-$17.55M$70.92M$16.6M$5.82M$8.46M-$24.83M$993K-$27.61M$49.33M-$5.98M$14.38M
Supplementary Data
Operating Cash Flow-$56.96M-$42.14M-$62.05M-$60.08M-$47.94M-$14.71M-$16.89M-$15.78M-$23.02M-$25.74M-$30.03M-$18.41M-$15.28M-$12.23M
Capital Expenditure-$185K-$3.38M-$10.48M-$4.46M-$939K-$307K-$29K-$2.01M-$276K-$320K-$1.95M-$3.32M-$604K-$79K
Free Cash Flow-$57.15M-$45.53M-$72.53M-$64.54M-$48.88M-$15.02M-$16.92M-$17.79M-$23.3M-$26.06M-$31.98M-$21.73M-$15.89M-$12.31M
Cash at Beginning$58.82M$39.46M$77.56M$95.11M$24.19M$7.6M$1.78M$7.22M$31.91M$30.91M$58.53M$8.73M$14.72M$339K
Cash at End$18.89M$58.82M$39.46M$77.56M$95.11M$24.19M$7.6M$15.68M$7.08M$31.91M$30.91M$58.06M$8.73M$14.72M